StonvexLoading…
StonvexStonvexStonvexCore line items from LSF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $49.89M | $43.30M | $34.22M | $35.83M |
Operating Income | $-3.41M | $-2.17M | $-10.70M | $-40.36M |
Net Income | $-3.25M | $-1.82M | $-10.16M | $-40.34M |
EPS (Diluted) | $-0.31 | $-0.18 | $-1.09 | $-4.41 |
Total Assets | $19.22M | $19.26M | $18.03M | $30.04M |
Total Liabilities | $7.76M | $6.06M | $4.62M | $7.53M |
Cash & Equivalents | $5.11M | $8.34M | $7.57M | $17.29M |
Free Cash Flow OCF − CapEx | $-2.86M | $840.73K | $-10.91M | $-15.47M |
Shares Outstanding | 10.69M | 10.29M | 9.38M | 9.21M |